Where does Illumix Surgical Canada Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Illumix Surgical Canada Inc. ranks #29,051 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Illumix Surgical Canada Inc. hold?

Illumix Surgical Canada Inc. holds 9 US utility patents granted between 2017 and 2025, spanning 3 technology areas.

What is Illumix Surgical Canada Inc.'s Innovation Score?

Illumix Surgical Canada Inc. has an Innovation Score of 29.4 out of 100 (31st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Illumix Surgical Canada Inc. focus on?

Illumix Surgical Canada Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 9 patents, ranking #1,889 of 7,127 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Illumix Surgical Canada Inc.'s patent grant rate increasing or decreasing?

Illumix Surgical Canada Inc.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Illumix Surgical Canada Inc.'s patents?

Illumix Surgical Canada Inc.'s patents average 17.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Illumix Surgical Canada Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Illumix Surgical Canada Inc.

USPTO PatentsView assignee record - 9 granted patents across 3 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Illumix ranks #29,051 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 3 technology areas.

#29,051
of 49,997 US assignees by volume: 31st percentile
by Innovation Score (29.4/100): 17.2
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29051 · Foreign Corporation #29,051 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #29,051/49,997
PHOTO-FINISH Ibex Innovations
CPC-NARROW A61B · 3 areas
INNOV-THIN 29.4/100
CLAIMS-RICH 17.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ibex Innovations Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Illumix’s 29.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (27%) Velocity 5.0 pts (17%) Breadth 6.1 pts (21%) Claim depth 10.3 pts (35%)

Qualcomm Incorporated · highest

85
ChemPartner · near

29
Beijing Niu… · near

29
Illumix Surgical… · this assignee

29
Mercury Kingdom Assets · near

29
selFrag · near

29
3D Lighting… · lowest

7

What this shows Illumix's Innovation Score is 29.4/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Illumix?

Each dot is one of Illumix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Illumix’s own 17.2 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Illumix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Illumix's grants concentrate

Illumix Surgical Canada Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2017. By volume, Illumix sits between Italfarmaco SPA and Immutep S.A.S..

Illumix's three-year grant acceleration

Illumix Surgical Canada Inc. shows 3 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Italfarmaco SPA

9
ITP

9
ITT Bornemann

9
Ibex Innovations

9
Illumon

9
Imaging Advantage

9
Immunome

9
Immutep S

9
Illumix Surgical… ◀

9

What this shows Illumix holds 9 patents at rank #29,080, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Illumix

By rank, the assignees closest to #29,080 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Illumix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Illumix, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Illumix ranks #1,889 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (29 here).

Mercury Kingdom Assets Limited 29 selFrag AG 29 Beijing Niu Information Technology Co., Ltd. 29 ChemPartner Corporation 29

Illumix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 31st percentile higher than 31% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Illumix Surgical Canada Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	11.1%
2019	3	33.3%
2021	1	11.1%
2022	2	22.2%
2024	1	11.1%
2025partial year	1	11.1%

Which technologies does Illumix Surgical Canada Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 9

F21V - Functional Features OR Details OF Lighting Devices OR Systems THEREOF; Structural Combinations OF Lighting Devices With Other Articles, NOT Otherwise Provided FOR 6

F21W - Indexing Scheme Associated With Subclasses F21k, F21l, F21s and F21v, Relating TO Uses OR Applications OF Lighting Devices OR Systems 3

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Illumix Surgical Canada Inc.'s patent record in context - here's where to go next.

Illumix Surgical Canada Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #29,051 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Illumix Surgical Canada Inc. against Italfarmaco SPA, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.